EU AI Act今日生效三项机制:Article 50透明度义务、GPAI处罚权和市场监管权。Digital Omnibus将高风险系统义务延期至2027年12月和2028年8月。延期与否的分界线在于是否需要协调技术标准——需要标准的义务延期,不需要标准的义务照常生效。10^25 FLOPs的系统性风险阈值今天开始可处罚。
AI-designed drugs clear safety trials at well above industry rates. At the stage that tests whether a drug works, the sources contradict each other, and the more careful ones report no advantage at al...
Enterprise AI is measured by what organisations sanctioned. A separate literature measures what their employees actually use, and the two describe the same companies without ever being set against eac...
Survey evidence says AI improves code quality. Repository telemetry says the opposite. They are measuring different things, and the gap between them is where the productivity went.
The best evidence for AI mental health support is a single randomised trial of a purpose-built clinical tool. Its own journal published three methodological objections, and almost nobody uses the thin...
Switching costs used to require board approval to incur. AI switching costs accumulate through ordinary engineering decisions nobody escalates, and the asset that creates them is the same one that pro...
The FDA has two AI tracks. One is final, has authorised over 1,350 devices, and is the regime under which almost none of them cite a trial. The other missed its own deadline five weeks ago.
Enterprise AI pilots are built on a curated slice, pre-cleaned, with limited users and manual review. Then production data arrives. That sequence explains the failure rate without invoking model capab...